Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trialsPrimo N Lara, James Moon, Mary W Redman, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 22, 2009
Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004Shun-Ichi Isa, Tomoya Kawaguchi, Satoshi Teramukai, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics AssayPrimo N Lara, James Moon, Paul J Hesketh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2014
Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancerJeffrey W Allen, James Moon, Mary Redman, et al.Cancer Treatment and Research Communications|July 25, 2017
Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor TherapyThomas J Semrad, Edward J Kim, Michael S Tanaka, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trialRandeep Sangha, Angela M Davies, Primo N Lara, et al.Investigational New Drugs|September 10, 2013
Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancerCheryl Ho, Angela M Davies, Randeep S Sangha, et al.Clinical Lung Cancer|February 24, 2015
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533Antoinette J Wozniak, James Moon, Charles R Thomas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on ErlotinibPrimo N Lara, Jeff Longmate, Philip C Mack, et al.The Prostate|June 4, 2004
Molecular alterations associated with LNCaP cell progression to androgen independenceXu-Bao Shi, Ai-Hong Ma, Clifford G Tepper, et al.Pageof 13